$CARL SEC Filings

Filed On	Filing
14 Oct 2026	144
06 Oct 2026	Form 4: Bertolini Jeffrey, Chief Operating Officer Received 747 shares by exercise or conversion ($4.42K) · Sold 747 shares ($10.7K)
05 Oct 2026	144
01 Oct 2026	Form 4: Bertolini Jeffrey, Chief Operating Officer Received 243 shares by exercise or conversion ($542) · Sold 243 shares ($3.4K)
01 Oct 2026	S-8
30 Sep 2026	Form 3: Kamocsay Jennifer, Chief Legal Officer Holds 56,222 shares of Common Stock
30 Sep 2026	Form 4: Heppenstall Richard, CFO, Treasurer Received 89,286 shares as a grant or award · Granted 180,137 Stock Option (Right to Buy)
30 Sep 2026	Form 3: Heppenstall Richard, CFO, Treasurer No securities owned
30 Sep 2026	144
30 Sep 2026	8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Regulation FD Disclosure This Employment Agreement (the “Agreement”) is entered into effective September 28, 2026 (the “Effective Date”), by and between Richard Heppenstall (“Executive”) and Carlsmed, Inc. (the “Company”).
15 Sep 2026	Form 4/A: Presidio Management Group XII, L.l.c., 10% owner and 2 others Bought 200,000 shares ($3M)
10 Sep 2026	Form 4: Bertolini Jeffrey, Chief Operating Officer Granted 50,000 Stock Option (Right to Buy)
10 Sep 2026	Form 3: Bertolini Jeffrey, Chief Operating Officer Holds 22,489 shares of Common Stock
08 Sep 2026	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure CARLSBAD, Calif., September 8, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced that Jeff Berto...
21 Aug 2026	EFFECT
14 Aug 2026	S-3
05 Aug 2026	10-Q
05 Aug 2026	8-K: Results of Operations and Financial Condition
22 Jun 2026	Form 4: Oboyle Kevin C, Director Received 13,698 shares as a grant or award
22 Jun 2026	Form 4: Sidow Kevin, Director Received 13,698 shares as a grant or award

Comments